Skip to main content
$2.63 -$0.02 (-0.8%)

04:00 PM EDT on 09/29/23

Puma Biotechnology Inc. (NASDAQ:PBYI)

CAPS Rating: 1 out of 5

Current Price $2.63 Mkt Cap $125.0M
Open $2.67 P/E Ratio -47.39
Prev. Close $2.63 Div. (Yield) $0.00 (0.0%)
Daily Range $2.60 - $2.74 Volume 105,881
52-Wk Range $2.08 - $5.16 Avg. Daily Vol. 156,068

Caps

How do you think NASDAQ:PBYI will perform against the market?

Add Stock to CAPS Watchlist

All Players

37 Outperform
20 Underperform
 

All-Star Players

5 Outperform
6 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:PBYI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFEBCapital (74.42)
Submitted July 06, 2018

I'm not going to bet against Auerbach. The successful lobbying for CHMP re-review is the latest example of his being able overcome naysayers. Given Nerlynx potential to win greater use and his past M&A exit with Cougar/JNJ, I'm thinking this one… More

YourDailyBear (42.75)
Submitted January 14, 2016

Puma has 0 Revenue and a $1.57 Billion market cap. Crazy overvalued and bearish trend.

Fools bullish on NASDAQ:PBYI are also bullish on:

Fools bearish on NASDAQ:PBYI are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PBYI.

Recs

1
Member Avatar TMFEBCapital (74.42) Submitted: 7/6/2018 3:45:30 PM : Outperform Start Price: $59.65 NASDAQ:PBYI Score: -151.04

I'm not going to bet against Auerbach. The successful lobbying for CHMP re-review is the latest example of his being able overcome naysayers. Given Nerlynx potential to win greater use and his past M&A exit with Cougar/JNJ, I'm thinking this one makes sense to buy here.

Recs

0
Member Avatar foolsgold83 (< 20) Submitted: 12/7/2017 12:57:33 AM : Outperform Start Price: $98.30 NASDAQ:PBYI Score: -159.81

Prior success with leadership. Successfully bringing approved drugs to market. Will either continue to grow with successful trials or be acquired.

Recs

1
Member Avatar YourDailyBear (42.75) Submitted: 1/14/2016 1:28:07 PM : Underperform Start Price: $49.32 NASDAQ:PBYI Score: +217.17

Puma has 0 Revenue and a $1.57 Billion market cap. Crazy overvalued and bearish trend.

Leaderboard

Find the members with the highest scoring picks in PBYI.

Score Leader

IBDContrarian

IBDContrarian (65.98) Score: +266.82

The Score Leader is the player with the highest score across all their picks in PBYI.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
IBDContrarian 65.98 4/8/2013 Underperform 5Y $30.95 -91.50% +175.31% +266.82 1 Comment
kevrose31 79.18 1/10/2014 Underperform 1Y $110.14 -97.61% +132.39% +230.00 0 Comment
SimonSaysSell 98.86 4/16/2014 Underperform NS $73.01 -96.40% +130.48% +226.88 0 Comment
sobek1 77.90 8/6/2014 Underperform 1Y $230.97 -98.86% +123.68% +222.54 0 Comment
YourDailyBear 42.75 1/14/2016 Underperform 1Y $49.32 -94.67% +122.51% +217.17 1 Comment
jayningpan 63.67 8/18/2014 Underperform 5Y $262.01 -99.00% +116.77% +215.77 0 Comment
bumpyjr 21.62 7/23/2014 Underperform 5Y $230.35 -98.86% +115.16% +214.02 0 Comment
jackbot 98.28 7/24/2014 Underperform 5Y $214.06 -98.77% +115.15% +213.92 0 Comment
theMetz 23.91 7/24/2014 Underperform 1Y $226.00 -98.84% +115.00% +213.83 0 Comment
newbie07 75.45 7/24/2014 Underperform 5Y $226.00 -98.84% +115.00% +213.83 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PBYI.